1 – 10 of 66
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Computed tomography with adjusted dose for body mass index may be superior to whole-body radiography especially in elderly patients with multiple myeloma
- Contribution to journal › Article
- 2022
-
Mark
Regional differences in treatment and outcome for myeloma patients in Sweden : A population based Swedish myeloma register study
- Contribution to journal › Article
-
Mark
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma : A randomised phase 2 trial by the Nordic Myeloma Study Group
- Contribution to journal › Article
-
Mark
Suppression of T-Cell Proliferation by Normal Density Granulocytes Led to CD183 Downregulation and Cytokine Inhibition in T-Cells
Westerlund, Julia LU ; Askman, Sandra LU ; Pettersson, Åsa LU ; Hellmark, Thomas LU
; Johansson, Åsa C M
LU
and Hansson, Markus
LU
(2022)
In Journal of Immunology Research
2022.
- Contribution to journal › Article
- 2021
-
Mark
Germline variants at SOHLH2 influence multiple myeloma risk
- Contribution to journal › Article
-
Mark
Burden of Treatment-Induced Peripheral Neuropathy in Patients with Multiple Myeloma in Sweden
Nahi, Hareth ; Walinder, Göran ; Patel, Vishal ; Qu, Ying ; Levine, Aaron ; Majer, Istvan ; Kutikova, Lucie ; Hellqvist Franck, Eva ; Svensson, Maria K. and Hansson, Markus LU
(2021)
In Acta Haematologica
144(5).
p.519-527
- Contribution to journal › Article
-
Mark
Bone Marrow Neutrophils of Multiple Myeloma Patients Exhibit Myeloid-Derived Suppressor Cell Activity
Petersson, Julia LU ; Askman, Sandra LU ; Pettersson, Åsa LU ; Wichert, Stina LU
; Hellmark, Thomas
LU
; Johansson, Åsa
LU
and Hansson, Markus
LU
(2021)
In Journal of Immunology Research
2021.
p.1-10
- Contribution to journal › Article
- 2020
-
Mark
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Cavo, Michele ; Hansson, Markus LU
and Sonneveld, Pieter
(2020)
In The Lancet Haematology
7(6).
p.456-468
- Contribution to journal › Article
-
Mark
Outcome and characteristics of non-measurable myeloma : A cohort study with population-based data from the Swedish Myeloma Registry
Wålinder, Göran ; Samuelsson, Jan ; Näsman, Per ; Hansson, Markus LU
; Juliusson, Gunnar
LU
; Forsberg, Karin
; Svensson, Ronald
; Linder, Olle
; Carlson, Kristina
and Kristinsson, Sigurdur Y.
, et al.
(2020)
In European Journal of Haematology
104(5).
p.376-382
- Contribution to journal › Article
-
Mark
Search for multiple myeloma risk factors using Mendelian randomization
Went, Molly ; Cornish, Alex J. ; Law, Philip J. ; Kinnersley, Ben ; van Duin, Mark ; Weinhold, Niels ; Försti, Asta LU ; Hansson, Markus LU
; Sonneveld, Pieter
and Goldschmidt, Hartmut
, et al.
(2020)
In Blood Advances
4(10).
p.2172-2179
- Contribution to journal › Article